Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Markets
/
China
/
ETF market
/
520500
/
Analysis
HUATAI-PINEBRIDGE FUND MANAGEMENT HANG SENG INNOVATIVE DRUG ETF CNY
520500
Shanghai Stock Exchange
520500
Shanghai Stock Exchange
520500
Shanghai Stock Exchange
520500
Shanghai Stock Exchange
Market closed
Market closed
No trades
See on Supercharts
Overview
Analysis
Discussions
Technicals
Seasonals
Key stats
Assets under management (AUM)
—
Fund flows (1Y)
—
Dividend yield (indicated)
—
Discount/Premium to NAV
7.2%
Shares outstanding
—
Expense ratio
0.60%
About HUATAI-PINEBRIDGE FUND MANAGEMENT HANG SENG INNOVATIVE DRUG ETF CNY
Issuer
Huatai-PineBridge Fund Management Co., Ltd.
Brand
Huatai
Home page
huatai-pb.com
Inception date
Dec 16, 2024
Structure
Open-Ended Fund
Index tracked
Hang Seng Innovative Drug Index yield - HKD - Benchmark TR Gross
Replication method
Physical
Management style
Passive
Primary advisor
Huatai-PineBridge Fund Management Co., Ltd.
ISIN
CNE100006GB7
Closely track the performance of the underlying index and seek to minimize tracking deviation and tracking err.
Show more
Classification
Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharmaceuticals
Geography
Hong Kong
Weighting scheme
Market cap
Selection criteria
Market cap
Returns
1 month
3 months
Year to date
1 year
3 years
5 years
Price performance
—
—
—
—
—
—
NAV total return
—
—
—
—
—
—
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows